Llorente A, Gonzalez De San Roman E, Moreno M, Manuel I, Giralt M, Rodriguez R (2014) Activity mediated by neurolipid (CB1 and LPA1) and neuropeptide (GAL1) receptors in a rat model with cholinergic basal forebrain lesion. Neuroscience 2014 Abstracts 307.25. Society for Neuroscience, Washington, DC.
Summary: The cholinergic basal forebrain neurons (CBFN) which innervate cortical, hippocampal and amygdaloid areas, control learning and memory processes and are damaged in Alzheimer´s disease. An intraparenquimal injection of the 192IgG-saporin (SAP) immunotoxin, specifically eliminates CBFN. The present study examined the activity of endocannabinoid (CB1), lysophosphatidic acid (LPA1), galanin (GAL1) and muscarinic (MR) receptors, measuring Gi/o protein activation by [35S]GTPγS autoradiography in rats after the selective cholinergic basal forebrain lesion. CB1 immunoreactivity (CB1-ir) was also analyzed in the SAP administration area. We observed a high CB1-ir in the basal forebrain of the lesioned rats. The autoradiographic assays revealed that WIN55,212-2 (10 μM) evoked stimulation (CB1 activity) was increased in lateral olfactory tract (data expressed in % stimulation over basal; CSF vs SAP; 55 ± 11% vs 128 ± 13%, p<0.05) and in entorhinal cortex (156 ± 17% vs 277 ± 30%, p<0.01), but decreased in hippocampal dentate gyrus (299 ± 37% vs 166 ± 21%, p<0.05) and in medial amygdala (116 ± 20% vs 50 ± 7%, p<0.05). LPA (10 μM) induced stimulation (LPA1 activity) showed an increase in the internal capsule (60 ± 10% vs 137 ± 19%, p<0.01). The MR activity that was measured using carbachol (100 μM) was increased in hippocampal dentate gyrus (27 ± 6% vs 62 ± 7%, p<0.05) and in entorhinal cortex (55 ± 10% vs 94 ± 11%, p<0.05) but decreased in the nucleus basalis of Meynert (nbM) (46 ± 10% vs 15 ± 6%, p<0.05). Finally, there was an increased stimulation (GAL1 activity) of galanin (1 μM) in the nbM (45 ± 13% vs 80 ± 12%, p<0.05). The CB1-ir and GAL1 activity was increased in the lesioned area where the cholinergic neurotransmission was impaired, indicating a possible neuroprotective action on the surviving CBFN.
Related Products: 192-IgG-SAP (Cat. #IT-01)